Literature DB >> 24155994

Acquired hemochromatosis with pronounced pigment deposition of the upper eyelids.

Anna H Chacon1, Brian Morrison, Shasa Hu.   

Abstract

HEMOCHROMATOSIS MAY BE CLASSIFIED INTO TWO GROUPS: primary (hereditary) or secondary (acquired). The acquired type most commonly occurs after massive intake of iron supplements or blood transfusions and is also known as transfusional iron overload. In the past, hemochromatosis was usually recognized at an advanced stage by the classic triad of hyperpigmentation, diabetes mellitus ("bronze diabetes"), and hepatic cirrhosis. Cutaneous hyperpigmentation is present in 70 percent of patients due to two different mechanisms: (1) hemosiderin deposition resulting in diffuse, slate-gray darkening and (2) increased production of melanin in the epidermis. A 47-year-old woman who receives regular transfusions due to low iron and chronic, unresolving anemia and who subsequently developed pronounced hyperpigmentation of the upper eyelids is described. The presentation, diagnosis, pathogenesis, and treatment options of hyperpigmentation due to secondary hemochromatosis are discussed.

Entities:  

Year:  2013        PMID: 24155994      PMCID: PMC3805307     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  15 in total

1.  Hemochromatosis and vitamin C.

Authors:  V Herbert
Journal:  Ann Intern Med       Date:  1999-09-21       Impact factor: 25.391

2.  Cutaneous hyperpigmentation during therapy with hydroxychloroquine.

Authors:  Boaz Amichai; Andera Gat; Marcelo H Grunwald
Journal:  J Clin Rheumatol       Date:  2007-04       Impact factor: 3.517

3.  Hemochromatosis and the skin.

Authors:  E P Cawley; Y T Hsu; B T Wood; P E Weary
Journal:  Arch Dermatol       Date:  1969-07

Review 4.  Cutaneous manifestations of metabolic diseases: uncommon presentations.

Authors:  Erich Köstler; Heiner Porst; Uwe Wollina
Journal:  Clin Dermatol       Date:  2005 Sep-Oct       Impact factor: 3.541

5.  Subconjunctival hemorrhages: presenting sign for hereditary hemochromatosis.

Authors:  Judy W H Tong; Mark H Sawamura
Journal:  Optom Vis Sci       Date:  2011-09       Impact factor: 1.973

Review 6.  The penetrance of hereditary hemochromatosis.

Authors:  Jill Waalen; Børge G Nordestgaard; Ernest Beutler
Journal:  Best Pract Res Clin Haematol       Date:  2005-06       Impact factor: 3.020

Review 7.  Recognition and management of hereditary hemochromatosis.

Authors:  David J Brandhagen; Virgil F Fairbanks; William Baldus
Journal:  Am Fam Physician       Date:  2002-03-01       Impact factor: 3.292

8.  Progressive pigmented purpuric dermatitis and alopecia areata as unusual skin manifestations in recognizing hereditary hemochromatosis.

Authors:  Vesna Sredoja Tišma; Stela Bulimbašić; Morana Jaganjac; Marica Stjepandić; Miljana Larma
Journal:  Acta Dermatovenerol Croat       Date:  2012       Impact factor: 1.256

Review 9.  Latest insights into skin hyperpigmentation.

Authors:  Jean-Paul Ortonne; Donald L Bissett
Journal:  J Investig Dermatol Symp Proc       Date:  2008-04

Review 10.  Hereditary hemochromatosis--a new look at an old disease.

Authors:  Antonello Pietrangelo
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

View more
  1 in total

Review 1.  Iron Therapy in Chronic Kidney Disease: Days of Future Past.

Authors:  Kuo-Hua Lee; Yang Ho; Der-Cherng Tarng
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.